Med Page Today

APRIL 8, 2024

(MedPage Today) -- ATLANTA -- The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first major trial testing this provocative idea. Compared with standard medical.

Plaque 119

Plaque Stent Stents 119

DAIC

OCTOBER 15, 2024

15, 2024 – Elucid has announced that four of the seven Medicare Administrative Contractors (MACs) will extend coverage for AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ image analysis software, beginning Nov. tim.hodson Tue, 10/15/2024 - 12:12 Oct.

Medicare 52

Medicare Plaque Chest Pain Coronary Artery Disease 52

Circulation: Cardiovascular Imaging

JANUARY 11, 2024

BACKGROUND:Recently, it was reported that noncalcified plaque (NCP) volume was an independent predictor for cardiac events. Plaque volume was measured by computed tomography angiography, plaque vulnerability by optical coherence tomography, and the level of coronary inflammation by PCAT attenuation. versus 75.9%;P<0.001),

Plaque 75

Plaque Cardiovascular Imaging Cholesterol Circulation 75

DAIC

APRIL 11, 2024

These new findings suggest that people with high-risk plaques that are likely to rupture could benefit from the procedure as a pre-emptive measure rather than waiting for a heart attack or other severe reduction in blood flow to occur. During PCI, an operator inserts a stent into a blocked artery through a catheter in the groin or arm.

Plaque 111

Plaque Heart attacks Heart Attack Coronary Artery Disease 111

American College of Cardiology

SEPTEMBER 13, 2024

Is calcified plaque burden (CPB) associated with vascular inflammation and plaque vulnerability?

Plaque 67

Plaque Article 67

Physiologically Speaking

JANUARY 5, 2024

In this 6-month randomized controlled study, twice-weekly HIIT reduced coronary plaque volume, increased aerobic fitness, and improved body composition in adults with stable heart disease, suggesting benefits for cardiovascular disease progression. Does this greater plaque presence put athletes at a greater risk of CVD events?

Plaque 114

Plaque Physiology Exercise Cholesterol 114

HCPLive

MARCH 13, 2024

Armstrong, MD, MPH, discusses emerging therapies in oral systemics for the treatment of plaque psoriasis and shares developments in TYK2 inhibition.

Plaque 98

Plaque 98

Open Heart

SEPTEMBER 19, 2024

Non-invasive coronary CT angiography (CCTA) enables evaluation of coronary plaque phenotype. This study investigates the relationship between a comprehensive panel of inflammatory markers and short-term plaque progression on serial CCTA imaging, hypothesising that inflammation is associated with increased plaque volume.

Plaque 52

Plaque Coronary Artery Disease Risk Factors Cardiovascular Disease 52

American College of Cardiology

JULY 24, 2024

What is the association of lipoprotein(a) (Lp[a]) levels with long-term coronary artery plaque progression, development of high-risk plaque, and pericoronary adipose tissue inflammation?

Plaque 56

Plaque Article 56

Dr. S. Venkatesan MD

OCTOBER 2, 2024

Doctor, do you have any investigation to know how much the total plaque burden is in my coronary artery? I recently read in Forbes Sunday health supplement, It says ,it is better to know the thickness of the cap covering the plaque. to decode the histological, biochemical, pathological secrets within the atherosclerotic plaques.

Plaque 52

Plaque Atherosclerosis Education Cholesterol 52

American College of Cardiology

NOVEMBER 20, 2024

A unique strength of coronary computed tomography angiography (CCTA) is the ability to noninvasively detect nonobstructive and obstructive coronary plaque.

Plaque 40

Plaque Article 40

HCPLive

MARCH 29, 2024

Dermatology physician assistants are talking about the evolving role of their profession in taking care of patients with plaque psoriasis.

Plaque 98

Plaque 98

Circulation

NOVEMBER 11, 2024

The sections were also used for immunohistochemistry with cell marker antibodies (to measure % plaque smooth muscle cells (SMC), macrophages (MF), and endothelial cells (EC)). to D: 30.7%), elevation in plaque MF (A: 16.7% to D: 22.5%), increase in plaque cell apoptosis (A: 5.2% to D:17.9%) and plaque EC (A:3.21% to D:1.48%).

Plaque 40

Plaque Atherosclerosis Heart Disease Circulation 40

American College of Cardiology

APRIL 12, 2024

Are high-risk plaque (HRP) features on coronary computed tomography angiography (CTA) associated with vulnerable plaque on optical coherence tomography (OCT)?

Plaque 74

Plaque Article 74

DAIC

MARCH 27, 2024

The registry will collect multi-site, real-world information on how the Plaque Analysis product provides enhanced patient insights, empowering physicians and helping to inform their medical management decisions for patients with suspected coronary artery disease (CAD). 2 “Data from the DECODE study shows the value of using Plaque Analysis.

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Anatomy 111

Journal of the American Heart Association

JANUARY 9, 2024

BackgroundProtruding aortic plaque is known to be associated with an increased risk for future cardiac and cerebrovascular events. Coronary plaque characteristics were compared to evaluate coronary plaque vulnerability in patients with protruding aortic plaque on computed tomography angiography.

Plaque 45

Plaque Aortic Myocardial Infarction Kidney Disease 45

DAIC

OCTOBER 16, 2024

15 , 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA). tim.hodson Wed, 10/16/2024 - 12:36 Oct. The four contractors for the U.S.

CMS 52

CMS Medicare Plaque Chest Pain 52

HCPLive

SEPTEMBER 17, 2024

At Maui Derm NP+PA Fall 2024, bimekizumab data demonstrates a consistent safety profile in moderate to severe plaque psoriasis over 4 years, with decreasing event rates over time.

Plaque 59

Plaque 59

HCPLive

JUNE 26, 2024

Dermatologists have a comprehensive discussion on systemic therapies for the treatment of plaque psoriasis, covering monitoring practices, and long term efficacy data for novel oral agent deucravacitinib.

Plaque 52

Plaque 52

DAIC

OCTOBER 30, 2024

Data confirm the use of FFR CT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease. The prospective data with long-term follow-up in ADVANCE-DK alongside Plaque Analysis data gave us far more than that. 27, 2024 — HeartFlow, Inc.

Plaque 52

Plaque Outcomes Coronary Artery Disease Chest Pain 52

Science Daily - Heart Disease

MARCH 5, 2024

Researchers have developed a new catheter-based device that combines two powerful optical techniques to image the dangerous plaques that can build up inside the arteries that supply blood to the heart.

Plaque 80

Plaque Cardiovascular Imaging Heart attacks Heart Attack 80

American College of Cardiology

MAY 30, 2024

Is vessel-level coronary atherosclerotic plaque activity using coronary 18F-sodium fluoride positron emission tomography (PET) associated with patient vessel-level myocardial infarction (MI)?

Plaque 68

Plaque Myocardial Infarction Article 68

HCPLive

OCTOBER 15, 2024

Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease. Lauren Miller, MPAS, PA-C; Jayme M.

Plaque 52

Plaque 52

Nature Reviews - Cardiology

JANUARY 22, 2024

Nature Reviews Cardiology, Published online: 23 January 2024; doi:10.1038/s41569-024-00993-4 Anti-inflammatory therapy involving IL-1β inhibition might reduce the risk of cardiovascular events in individuals with clonal haematopoiesis by increasing the number of fibroblast-like cells in the fibrous cap region of atherosclerotic plaques, thereby stabilizing (..)

Plaque 81

Plaque 81

HCPLive

OCTOBER 1, 2024

Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease. Lauren Miller, MPAS, PA-C; Jayme M.

Plaque 52

Plaque 52

American College of Cardiology

APRIL 8, 2024

The goal of the PREVENT trial was to compare the safety and efficacy of medical therapy along with focal preventive PCI of non-flow-limiting vulnerable plaque compared with medical therapy alone.

Plaque 75

Plaque Stenosis Article 75

HCPLive

APRIL 5, 2024

Physician assistants TJ Chao and Kristine Kucera discuss how the understanding of plaque psoriasis has changed over time and is now considered a systemic disease.

Plaque 52

Plaque 52

Nature Reviews - Cardiology

MARCH 17, 2024

Nature Reviews Cardiology, Published online: 18 March 2024; doi:10.1038/s41569-024-01015-z In patients with carotid artery disease, the presence of microplastics and nanoplastics in the carotid plaque is associated with an increased risk of death or major cardiovascular events compared with patients in whom microplastics and nanoplastics were not detected. (..)

Plaque 72

Plaque 72

Medical Xpress - Cardiology

DECEMBER 13, 2023

Aging is known to be a risk factor for the biological changes that create the dangerous buildup of plaque in arteries called atherosclerosis, and aging also induces a buildup of memory CD8 T cells, a type of immune cell, in mice and humans.

Plaque 92

Plaque Atherosclerosis Risk Factors 92

HCPLive

MARCH 20, 2024

An expert in dermatologic conditions examines laboratory requirements for initiating deucravacitinib in patients with moderate-to-severe plaque psoriasis and the impact of deucravacitinib on the treatment landscape.

Plaque 52

Plaque Laboratory 52

DAIC

MAY 23, 2024

a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging. milla1cf Thu, 05/23/2024 - 08:00 May 23, 2024 — HeartFlow, Inc. ,

Plaque 52

Plaque Coronary Artery Disease Technology Anatomy 52

HCPLive

AUGUST 14, 2024

Plaque psoriasis experts explore recent advancements in treatment options, patient experiences, and the potential of novel oral systemic therapies to reduce the burden of this prevalent chronic condition.

Plaque 52

Plaque 52

Frontiers in Cardiovascular Medicine

APRIL 24, 2024

The early detection of plaques by circulating biomarkers is highly clinically relevant to prevent the occurrence of major complications such as stroke or heart attacks. miRNA expression profiles of serum-derived EVs were obtained by small RNA sequencing and in plaque material simultaneously acquired from patients.

Plaque 52

Plaque Biomarkers Circulation Stenosis 52

American College of Cardiology

JUNE 18, 2024

Yancy, MD, MSc, MACC discuss insights from data and studies involving plaque burden, morphology and flow. In this interview, Andrew Choi, MD, FACC and Clyde W.

Plaque 51

Plaque Article 51

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Background To investigate the correlation between lg (circSCMH1/miR-874) and acute coronary syndrome (ACS), acute myocardial infarction (AMI), and carotid plaque stability. Compared with the low-risk plaque and control groups, the lg (circSCMH1/miR-874) value of medium-high risk plaque group decreased ( P  < 0.05).

Plaque 59

Plaque SCAD Coronary Artery Disease Myocardial Infarction 59

HCPLive

JUNE 26, 2024

A panel of dermatologists have a comprehensive discussion on exciting developments in the treatment of plaque psoriasis, focusing on treatment approaches, patient monitoring strategies, and recent clinical trial data.

Plaque 52

Plaque 52

HCPLive

JULY 31, 2024

Plaque psoriasis experts explore recent advancements in treatment options, patient experiences, and the potential of novel oral systemic therapies to reduce the burden of this prevalent chronic condition.

Plaque 52

Plaque 52